Viral vectors for gene transfer into antigen presenting cells.
Curr Opin Mol Ther
; 1(5): 558-64, 1999 Oct.
Article
em En
| MEDLINE
| ID: mdl-11249662
ABSTRACT
Crucial insights for vaccine development have come from examining how the immune system responds to antimicrobial vaccines, as well as to viral vectors employed for gene therapy. The effectiveness of a vaccine depends upon both the method of antigen delivery and the presentation of antigen to lymphocytes. Much focus has turned to delivering antigens to dendritic cells, to promote clinically beneficial T- and B-cell responses. Recombinant viral vectors represent a powerful vehicle to deliver genes encoding microbial- or tumor-derived antigens to generate clinically beneficial immunity. Dendritic cell-based and viral vector-based vaccines are currently being evaluated in clinical trials as a means of inducing antitumor immunity.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Técnicas de Transferência de Genes
/
Vetores Genéticos
/
Células Apresentadoras de Antígenos
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Curr Opin Mol Ther
Assunto da revista:
BIOLOGIA MOLECULAR
/
TERAPEUTICA
Ano de publicação:
1999
Tipo de documento:
Article
País de afiliação:
Estados Unidos